Wondering how much CJC-1295 with DAC should I take? Research protocols typically use 1–2 mg per week. See dosage tables, reconstitution math, and safety notes.
Most research protocols for CJC-1295 with DAC use 1 to 2 mg per week, delivered as one weekly subcutaneous injection or split into two doses of 0.5 to 1 mg every three or four days. That range traces back to early clinical work using roughly 30 mcg per kilogram of body weight per week, which lands near 2 mg weekly for a 70 to 80 kg adult. There is no FDA-approved human dose of CJC-1295 with DAC, so anyone asking how much cjc 1295 with dac should i take is reading research literature and self-reported logs, not a prescribing label.
What CJC-1295 With DAC Is and Why the Amount Is So Small
CJC-1295 is a growth hormone-releasing hormone (GHRH) analog. The letters DAC stand for Drug Affinity Complex, a maleimide group that attaches the peptide to albumin circulating in the blood.
That albumin binding is what makes the schedule unusual. A plain GHRH analog such as Mod GRF(1-29) clears the body in about 30 minutes, while CJC-1295 with DAC has a half-life of roughly six to eight days.
Because the DAC extends the half-life to about six to eight days, one or two injections per week are enough to keep blood levels steady.
| Form | Half-life | Typical injection frequency | Typical weekly amount in research |
|---|---|---|---|
| CJC-1295 with DAC | About 6 to 8 days | 1 to 2 times per week | 1 to 2 mg total |
| CJC-1295 without DAC (Mod GRF 1-29) | About 30 minutes | 2 to 3 times daily | 100 to 300 mcg per dose |
CJC-1295 With DAC Dosage Ranges Reported in Research
No single protocol is universally accepted, but the schedules below cover nearly every plan found in studies and published guides. Published cjc-1295 with dac dosage ranges cluster tightly between 1 mg and 2 mg per week.
| Weekly dose | How it is split | Volume per injection at 2.5 mg/mL |
|---|---|---|
| 0.5 mg | One injection per week | 0.2 mL (20 units) |
| 1 mg | One injection per week | 0.4 mL (40 units) |
| 2 mg | One injection per week | 0.8 mL (80 units) |
| 1 mg | Two 0.5 mg injections | 0.2 mL (20 units) each |
| 2 mg | Two 1 mg injections | 0.4 mL (40 units) each |
A common middle ground is 1 mg twice per week, which totals 2 mg weekly while keeping each injection volume small. Some people start lower, at 0.5 to 1 mg weekly, and adjust based on how they respond.
How to Dose CJC 1295 With DAC: Reconstitution Math
Learning how to dose cjc 1295 with dac starts with the vial, not the syringe. A standard cjc-1295 with dac 5mg vial is mixed with bacteriostatic water, and the final concentration depends entirely on how much water you add.
- 5 mg vial + 1 mL water = 5 mg/mL. A 1 mg dose is 0.2 mL, or 20 units on a U-100 insulin syringe.
- 5 mg vial + 2 mL water = 2.5 mg/mL. A 1 mg dose is 0.4 mL, or 40 units.
- 5 mg vial + 2.5 mL water = 2 mg/mL. A 1 mg dose is 0.5 mL, or 50 units.
A 5 mg vial reconstituted with 2 mL of bacteriostatic water gives a concentration of 2.5 mg/mL, so a 1 mg dose equals 40 units on a U-100 insulin syringe. Run the water down the inside wall of the vial and swirl gently rather than shaking, since foaming can damage the peptide. Reconstituted vials belong in the refrigerator, protected from light.
How Long Can You Take CJC-1295 With DAC?
Most documented protocols run 8 to 16 weeks, followed by a break of four weeks or longer. Some users stretch that to six months, though no long-term human safety data supports extended use.
The same caution applies when researchers ask how long can you take cjc 1295 ipamorelin, because the two peptides are frequently stacked. Ipamorelin is usually dosed at 100 to 300 mcg once to three times daily, while the DAC version of CJC-1295 is dosed weekly.
Because the half-life is long, effects build slowly. Many users report noticing changes only after four to six weeks, which is one reason a two-week trial tells you very little.
CJC-1295 with DAC takes roughly 30 to 40 days to clear from the body after the final injection.
Side Effects and Safety Considerations
CJC-1295 with DAC is not FDA-approved for human use in the United States, and peptides sold online are frequently unregulated, underdosed, or mislabeled. Reported side effects in research and user logs include:
- Redness, swelling, or soreness at the injection site
- Water retention and puffiness in the hands, feet, or face
- Joint stiffness or carpal tunnel-like numbness and tingling
- Headache, flushing, or dizziness soon after an injection
- Increased hunger, fatigue, or shifts in blood sugar
Raised growth hormone and IGF-1 levels deserve extra caution for anyone with a history of cancer, diabetes, or pituitary disease. Bloodwork for IGF-1 and glucose is common in longer protocols, and speaking with a healthcare professional before using any research peptide is the safest approach.
What Forum Threads Get Right and Wrong
Community logs can be helpful for practical details such as injection timing, storage, and how people titrate their weekly amount. They are not evidence of safety or effectiveness.
Two problems recur in those discussions: inconsistent product quality and dose escalation. Forum anecdotes cannot replace clinical data, and purity varies widely from one vendor to the next, so a third-party certificate of analysis matters more than a popular brand name.
Injection timing also gets more attention than it deserves for this peptide. With a half-life measured in days, hitting the exact hour of the day matters far less than keeping the weekly total steady.
Frequently Asked Questions
How much CJC-1295 with DAC should I take per week?
Research protocols most often use 1 to 2 mg per week, given as one weekly injection or split into two doses every three or four days. The figure comes from studies using about 30 mcg per kilogram of body weight weekly. CJC-1295 with DAC has no FDA-approved human dose, so these numbers are research references rather than medical recommendations.
Do you need to stack CJC-1295 with DAC and ipamorelin?
Many users stack them because CJC-1295 acts on GHRH receptors while ipamorelin acts on ghrelin receptors, which may amplify growth hormone release. Typical research amounts are 1 to 2 mg of CJC-1295 with DAC weekly plus 100 to 300 mcg of ipamorelin once to three times daily. Stacking also increases the chance of side effects, so it should be discussed with a healthcare professional.
How long does CJC-1295 with DAC stay in your system?
The DAC extends the half-life to roughly six to eight days, so a single injection stays active for well over a week. Complete clearance takes about five half-lives, which works out to 30 to 40 days after the last dose. That long tail is why weekly dosing is standard and why side effects can linger after stopping.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.